CNBC - Health
Eli Lilly accuses church bishops, businessmen of fraud in Trulicity drug rebate scheme
18 hours ago
Trump says he's 'concerned' about Ebola after American tests positive in Africa2 days ago
White House adds generic drugs to direct-to-consumer TrumpRx site2 days ago
CDC says American tests positive for Ebola in Africa, risk in U.S. remains low2 days ago
FDA shuffles top drug, biologics leaders in latest leadership shakeup5 days ago
Bristol Myers Squibb turns to China to develop new drugs5 days ago
CDC says there are no U.S. hantavirus cases currently, 41 people being monitored6 days ago
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data6 days ago
Hantavirus isn't another Covid, but experts say it's testing U.S. readiness6 days ago
Trump says Makary resigns as FDA commissioner following backlash6 days ago
Novo Nordisk: High-dose Wegovy caused nearly 28% weight loss in some patients8 days ago
Jim Cramer says today's market is punishing stocks harder than 19999 days ago
Hantavirus cases spark brief surge in pharma and biotech stocks — here's why trading is so volatile9 days ago
Cruise ship hantavirus outbreak: An expedition boom and new world of travel risk9 days ago
Fitness wearable Whoop to offer on-demand clinician access to U.S. users12 days ago
Healthy Returns: Novo Nordisk faces Ozempic generics in Canada12 days ago
Planet Fitness stock plunges 30% after company slashes guidance13 days ago
Family office deal-making rebounds in April with healthcare bets13 days ago
Rare disease families find roadmap to drug development at bootcamps13 days ago
Novo Nordisk CEO says the drugmaker is more active than ever for dealmaking13 days ago
Wearable patches: How Barrière is trying to disrupt the supplement industry14 days ago
CVS blows past estimates, hikes outlook as insurance business outperforms14 days ago
FDA withdrew studies finding Covid and shingles vaccines were safe14 days ago
FDA commissioner defends agency's drug approval decisions after wave of backlash15 days ago
Major health insurers show early strength – but a key test looms in Q215 days ago
Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth15 days ago
Novo's head start on GLP-1 pills forces investors to rethink Lilly's dominance15 days ago
Weight loss and hair loss: The growing hair treatment market from GLP-1s18 days ago
Cardinal Health's sell-off on earnings was an overreaction. We'd be buyers19 days ago
Trump picks Nicole Saphier for surgeon general after pulling Casey Means19 days ago
Eli Lilly shares surge on a beat-and-raise, proving the stock's swoon was a mistake20 days ago
FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list20 days ago
